Danaher Aktie
WKN: 866197 / ISIN: US2358511028
22.10.2020 12:10:34
|
Danaher Guides Q4 Revenue Growth Below Estimates - Quick Facts
(RTTNews) - While reporting financial results for the third quarter on Thursday, medical company Danaher Corp. (DHR) said it anticipates adjusted core revenue growth for the fourth quarter, including Cytiva, to be in the low-double digit range.
On average, analysts polled by Thomson Reuters expect the company to report revenue growth of 27.1 percent to $6.19 billion or the quarter.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Danaher Corp.mehr Nachrichten
Analysen zu Danaher Corp.mehr Analysen
Aktien in diesem Artikel
Danaher Corp. | 177,96 | -1,13% |
|